주식/증권 📉 부정적 OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even Seeking Alpha - Market News 2026/08/05 02:21:25 4회 원문 기사 보기